バイオメディカル・ファジィ・システム学会大会講演論文集
Online ISSN : 2424-2586
Print ISSN : 1345-1510
ISSN-L : 1345-1510
セッションID: 9P-B-1
会議情報

9P-B-1 全身を一度に診られる腫瘍マーカー検査の意義と実際(B会場 一般講演)
牧野 健一堤 久美子朝長 健太平野 昌英平野 英保
著者情報
会議録・要旨集 フリー

詳細
抄録

In Japan, we received medical services without high price used by the medical care insurance. But, the Japanese insurance does not support whole disease. In particular, that uses hard to preventive medicines. We introduced the medical care without the insurance. The customers will pay high price money, but they receive preventive measures, in order to not adaptation to insurance. In this paper, we show the care of the earlier stage tumor used by the tumor markers. As results, 1. The people who have normal values of tumor markers. We did nothing. 2. The people who have disorder values of tumor markers. After pathological examination, we found early stage tumor. We removed tumor by surgical operation. And we had controlled metastasis used by method of GEP. 3. The people who indicate less disorder values of tumor markers. They has invisible earlier stage tumor. We introduced thiamine, glutathione and selenium ; these supplements activate the pentose phosphate pathway. As result. Their values of the tumor marker decreased than normal value.

著者関連情報
© 2010 バイオメディカル・ファジィ・システム学会
前の記事 次の記事
feedback
Top